These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18438706)

  • 1. Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
    Stambolic V; Woodgett JR; Fantus IG; Pritchard KI; Goodwin PJ
    Breast Cancer Res Treat; 2009 Mar; 114(2):387-9. PubMed ID: 18438706
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
    Hadad SM; Appleyard V; Thompson AM
    Breast Cancer Res Treat; 2009 Mar; 114(2):391. PubMed ID: 18421577
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
    Barba M; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin as an addition to conventional chemotherapy in breast cancer.
    Grenader T; Goldberg A; Shavit L
    J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it time to test metformin in breast cancer clinical trials?
    Cazzaniga M; Bonanni B; Guerrieri-Gonzaga A; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):701-5. PubMed ID: 19240238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin, B(12), and enhanced breast cancer response to chemotherapy.
    Garcia A; Tisman G
    J Clin Oncol; 2010 Jan; 28(2):e19; author reply e20. PubMed ID: 19949002
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
    Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The perioperative management of metformin for the oral and maxillofacial surgery patient: risks and recommendations.
    Blyer SM; Yelon JA
    J Oral Maxillofac Surg; 2007 Jan; 65(1):122-7. PubMed ID: 17174776
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?
    Goodwin PJ
    J Clin Oncol; 2008 Feb; 26(6):833-4. PubMed ID: 18281653
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin--long-term results.
    TreatmentUpdate; 2001; 13(7):4-5. PubMed ID: 11794860
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
    Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
    J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
    [No Abstract]   [Full Text] [Related]  

  • 15. Is metformin safe in patients with mild renal insufficiency?
    Kazory A; Walsh K; Harman E; Talor Z
    Diabetes Care; 2007 Feb; 30(2):444. PubMed ID: 17259530
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of vitamin B12 deficiency revised].
    Vrijsen BE; van der Meulen J
    Ned Tijdschr Geneeskd; 2006 Feb; 150(8):460; author reply 461. PubMed ID: 16538850
    [No Abstract]   [Full Text] [Related]  

  • 18. Does glucose infusion exacerbate metformin-associated lactate acidosis? A case report.
    Brouwers MC; Schaper N; Keeris L
    Diabetes Res Clin Pract; 2009 Jul; 85(1):e1-3. PubMed ID: 19427052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DIGAMI 2: breaking the spell of insulin for heart infarct. Re the article in DMW 45/2004].
    Martin J
    Dtsch Med Wochenschr; 2005 Jan; 130(4):175; author reply 175. PubMed ID: 15714684
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.